BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1191549)

  • 1. Phagocytes and C4 in paraproteinaemia.
    Spitler LE; Spath P; Petz L; Cooper N; Fudenberg HH
    Br J Haematol; 1975 Feb; 29(2):279-92. PubMed ID: 1191549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the paraproteins and clinical significance of more than one paraprotein and clinical significance of more than one paraprotein in serum of 56 patients.
    Gore ME; Riches PG; Kohn J
    J Clin Pathol; 1979 Apr; 32(4):313-7. PubMed ID: 109473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classical pathway complement activation in association with paraproteinaemia.
    Naish PF; Collins C; Barratt J
    Immunology; 1977 Oct; 33(4):517-21. PubMed ID: 924520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclasses IgG1--IgG4 in 84 sera with IgG paraprotein.
    Tichý M; Hrncír Z; Mracek J
    Neoplasma; 1978; 25(1):107-10. PubMed ID: 634402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucocyte function in paraproteinaemia.
    Ziegler JB; Hansen PJ; Penny R
    Aust N Z J Med; 1975 Feb; 5(1):39-43. PubMed ID: 809026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin and complement deposits in lupus glomerulonephritis.
    Méry JP; Morel-Maroger L; Boelaert J
    Proc Eur Dial Transplant Assoc; 1975; 11():506-11. PubMed ID: 1197274
    [No Abstract]   [Full Text] [Related]  

  • 7. Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.
    Wisnieski JJ; Knauss TC; Yike I; Dearborn DG; Narvy RL; Naff GB
    J Immunol; 1994 Mar; 152(6):3199-209. PubMed ID: 8144914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: C1-esterase inactivators and C4 in malignant diseases.
    Bach-Martensen N; Osther K; Stroyer I
    Lancet; 1975 Sep; 2(7933):499-500. PubMed ID: 51308
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of C1s and C4. A binding phenomenon.
    Taubman SB
    Biochim Biophys Acta; 1975 Jun; 393(2):542-55. PubMed ID: 125105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement component analysis in angiodema. Diagnostic value.
    Brasher GW; Starr JC; Hall FF; Spiekerman AM
    Arch Dermatol; 1975 Sep; 111(9):1140-2. PubMed ID: 1167046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS.
    Preuss KD; Pfreundschuh M; Ahlgrimm M; Fadle N; Regitz E; Murawski N; Grass S
    Int J Cancer; 2009 Aug; 125(3):656-61. PubMed ID: 19405124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subacute (de Quervain's) thyroiditis: association with HLA-Bw35 antigen and abnormalities of the complement system, immunoglobulins and other serum proteins.
    Nyulassy S; Hnilica P; Buc M; Guman M; Hirschová V; Stefanovic J
    J Clin Endocrinol Metab; 1977 Aug; 45(2):270-4. PubMed ID: 885992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement metabolism in man: hypercatabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary, angioedema (HAE).
    Carpenter CB; Ruddy S; Shehadeh IH; Müller-Eberhard HJ; Merrill JP; Austen KF
    J Clin Invest; 1969 Aug; 48(8):1495-505. PubMed ID: 4894302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of decreased leucocyte adhesiveness and migration in plasma from patients with IgG myelomatosis.
    Hopen G; Glette J; Matre R
    Scand J Haematol; 1984 Jan; 32(1):88-94. PubMed ID: 6695153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraproteinaemia: use of idiotypic determinants as specific markers for tumour activity.
    King MA; Vivianwells J
    Clin Exp Immunol; 1981 Sep; 45(3):544-51. PubMed ID: 6175454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast liver catabolism of C1q in patients with paraproteinaemia and depletion of the classical pathway of complement.
    Schifferli JA; Pascual M; Steiger G; Schapira M; Ryser JE; Estreicher J; Dash A
    Clin Exp Immunol; 1987 Jul; 69(1):188-97. PubMed ID: 3498586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical and clinical characteristic of series of 516 paraproteinemic patients.
    Tichý M; Hrncir Z; Mracek J; Hrncirová L; Matĕja F
    Neoplasma; 1978; 25(4):477-81. PubMed ID: 99675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of treatment with 17 alpha-alkylated androgens on C4 conversion products in hereditary angioedema studied by crossed immunoelectrophoresis.
    Bergamaschini L; Cicardi M; Tucci A; Agostoni A
    J Clin Pathol; 1982 Jul; 35(7):728-31. PubMed ID: 7096594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of paraprotein transport into the saliva by using anti-idiotype antibodies.
    Kubagawa H; Bertoli LF; Barton JC; Koopman WJ; Mestecky J; Cooper MD
    J Immunol; 1987 Jan; 138(2):435-9. PubMed ID: 3794339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic evaluation of rheumatoid arthritis and therapy with levamisole.
    Verhaegen H; de Cree J; de Cock W; Schuermans Y; Engels M; Sonck W
    Biomedicine; 1977 Jul; 26(4):283-91. PubMed ID: 922113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.